TORONTO--(BUSINESS WIRE)--Xagenic, a molecular diagnostics company developing the Xagenic X1™ platform for use at the point of care, today announced that Randall Wilhoite has joined the Company as Vice President of Operations. Wilhoite will oversee manufacturing and operations to ensure the company's commercial objectives for the Xagenic X1 platform are met.